Total Payments
$20,331
2024 Payments
$4,438
Companies
64
Transactions
1,245
Medicare Patients
5,674
Medicare Billing
$932,632
Payment Breakdown by Category
Food & Beverage$20,070 (98.7%)
Other$159.52 (0.8%)
Education$101.78 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,070 | 1,233 | 98.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $159.52 | 9 | 0.8% |
| Education | $101.78 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,812 | 122 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,228 | 82 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,192 | 83 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,185 | 73 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,006 | 73 | $0 (2022) |
| Eisai Inc. | $994.30 | 51 | $0 (2024) |
| UCB, Inc. | $726.77 | 45 | $0 (2024) |
| MDD US Operations, LLC | $712.84 | 18 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $660.98 | 31 | $0 (2024) |
| SK Life Science, Inc. | $627.42 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,438 | 216 | ABBVIE INC. ($521.86) |
| 2023 | $3,504 | 199 | ABBVIE INC. ($444.13) |
| 2022 | $2,987 | 186 | ABBVIE INC. ($316.42) |
| 2021 | $2,131 | 133 | Teva Pharmaceuticals USA, Inc. ($269.60) |
| 2020 | $1,081 | 74 | Sunovion Pharmaceuticals Inc. ($186.95) |
| 2019 | $2,252 | 156 | Sunovion Pharmaceuticals Inc. ($232.05) |
| 2018 | $2,121 | 142 | Sunovion Pharmaceuticals Inc. ($267.11) |
| 2017 | $1,818 | 139 | Novartis Pharmaceuticals Corporation ($197.56) |
All Payment Transactions
1,245 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.04 | General |
| 12/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Neuroscience | ||||||
| 12/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Neurology | ||||||
| 12/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Musculoskeletal | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Neurology | ||||||
| 12/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $29.25 | General |
| 12/03/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: RETT SYNDROME | ||||||
| 11/26/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: Neuroscience | ||||||
| 11/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: Rare Disease | ||||||
| 11/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Neurology | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PAIN | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $0.68 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,457 | 46,484 | $1.2M | $280,663 |
| 2022 | 18 | 1,339 | 12,134 | $714,694 | $215,740 |
| 2021 | 18 | 1,406 | 10,391 | $678,348 | $225,338 |
| 2020 | 20 | 1,472 | 9,072 | $665,639 | $210,891 |
Total Patients
5,674
Total Services
78,081
Medicare Billing
$932,632
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 461 | 773 | $146,870 | $63,042 | 42.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 13 | 8,400 | $100,800 | $40,241 | 39.9% |
| J0174 | Injection, lecanemab-irmb, 1 mg | Office | 2023 | 14 | 34,360 | $377,960 | $36,244 | 9.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 256 | 260 | $163,280 | $32,184 | 19.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 1,560 | $84,240 | $28,685 | 34.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 70 | 71 | $69,225 | $18,698 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 127 | 127 | $31,178 | $13,152 | 42.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 113 | 179 | $47,200 | $11,864 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 145 | $19,575 | $7,919 | 40.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 53 | 53 | $36,517 | $6,191 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 36 | $9,540 | $4,531 | 47.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 14 | 43 | $23,693 | $3,951 | 16.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 43 | $16,555 | $3,902 | 23.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 73 | $14,819 | $3,080 | 20.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 20 | 20 | $20,540 | $2,947 | 14.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 19 | 19 | $11,305 | $1,606 | 14.2% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 18 | 18 | $6,804 | $1,395 | 20.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 40 | $2,440 | $382.58 | 15.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 45 | $1,080 | $378.00 | 35.0% |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 2023 | 17 | 219 | $2,844 | $270.51 | 9.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 437 | 742 | $140,980 | $62,858 | 44.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 17 | 9,200 | $110,400 | $42,388 | 38.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 214 | 214 | $134,392 | $26,631 | 19.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 62 | 63 | $61,425 | $16,741 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 123 | 123 | $30,198 | $13,132 | 43.5% |
About Dr. Christopher Lynn, MD
Dr. Christopher Lynn, MD is a Neurology healthcare provider based in Hattiesburg, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386759603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Lynn, MD has received a total of $20,331 in payments from pharmaceutical and medical device companies, with $4,438 received in 2024. These payments were reported across 1,245 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($20,070).
As a Medicare-enrolled provider, Lynn has provided services to 5,674 Medicare beneficiaries, totaling 78,081 services with total Medicare billing of $932,632. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Hattiesburg, MS
- Active Since 08/19/2006
- Last Updated 06/01/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386759603
Products in Payments
- NUPLAZID (Drug) $1,125
- APTIOM (Drug) $1,036
- BOTOX (Biological) $691.32
- Fycompa (Drug) $618.59
- ZEPOSIA (Drug) $546.91
- QULIPTA (Drug) $545.69
- AUBAGIO (Drug) $543.81
- KESIMPTA (Drug) $540.17
- NURTEC ODT (Drug) $526.65
- INGREZZA (Drug) $517.56
- Aimovig (Biological) $445.66
- UBRELVY (Drug) $432.43
- ULTOMIRIS (Biological) $430.73
- Gocovri (Drug) $420.20
- GILENYA (Drug) $412.27
- Leqembi (Drug) $375.71
- NUEDEXTA (Drug) $358.98
- Briviact (Drug) $354.07
- INBRIJA (Drug) $350.24
- AUSTEDO (Drug) $309.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hattiesburg
Ronald Schwartz, Md, MD
Neurology — Payments: $254,813
Neurology $254,813
Joshua Maksi, Md, MD
Neurology — Payments: $26,846
Neurology $26,846
Jose Fernandez, Md, MD
Neurology — Payments: $21,009
Neurology $21,009
Keith Jones, M.d, M.D
Neurology — Payments: $2,086
Neurology $2,086
Dr. Dave Roberts, M.d, M.D
Neurology — Payments: $201.41
Neurology $201.41
Nathaniel Nowacki, M.d, M.D
Neurology — Payments: $182.51
Neurology $182.51